Analyst firms · BofA Securities · TDOC
BofA Securities TDOC price target and rating history
Teladoc Health Inc. (TDOC) · Health Care
BofA Securities rates Teladoc Health Inc. (TDOC) Buy with a $7 price target, as of its latest action on Feb 26, 2026. It has published 4 rating actions on TDOC since October 2021, including 1 upgrade and 0 downgrades. Across 3 firms with a TDOC price target in the last 12 months, the median target is $8.50. BofA Securities's $7 is 18% below that.
- Current rating
- Buy
- Price target
- $7
- Median target, all firms
- $8.50
- Actions on TDOC
- 4
BofA Securities price target on TDOC
Every BofA Securities rating on TDOC
- Feb 26, 2026
- Jul 6, 2022
- Feb 23, 2022
- Oct 28, 2021
How other firms rate TDOC
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Argus Research | Sell | Nov 2, 2026 | |
| Deutsche Bank | Buy | $11 | Mar 10, 2026 |
| BofA Securities | Buy | $7 | Feb 26, 2026 |
| Barclays | Equal Weight | $8.50 | Dec 9, 2025 |
Questions about BofA Securities and TDOC
- What is BofA Securities's price target for TDOC?
- BofA Securities's latest stated price target for Teladoc Health Inc. (TDOC) is $7, from its action on Feb 26, 2026.
- What is BofA Securities's rating on TDOC?
- BofA Securities rates TDOC Buy, a bullish rating, as of Feb 26, 2026.
- When did BofA Securities last change its view on TDOC?
- On Feb 26, 2026, BofA Securities upgrades to Buy from Neutral, price target $7.
- How does BofA Securities's TDOC target compare with other analysts?
- Across 3 firms with a TDOC price target in the last 12 months, the median target is $8.50. BofA Securities's $7 is 18% below that.
More TDOC rating histories
- Argus Research4
- Deutsche Bank4
- Barclays4
- Goldman Sachs4
- Jefferies3
- Leerink Partners7
- Guggenheim4
- KeyBanc Capital Markets3
- Needham4
- Wells Fargo3
- Citigroup3
- Credit Suisse4
- Piper Sandler3
- Oppenheimer4
All BofA Securities ratingsTDOC news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.